Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn's disease (PROSE): a 16-week follow-up.

Anders ForssMark ClementsPär MyrelidHans StridCharlotte SödermanAgnieszka WagnerDavid AnderssonFredrik Hjelmnull nullOla OlénJonas F LudvigssonJonas Halfvarson

Published in: Scandinavian journal of gastroenterology (2021)

In this nation-wide prospective real-world study of adult patients with CD, ustekinumab was associated with clinical effectiveness when administered according to clinical practice and seemed to represent a safe treatment option.

Keyphrases

clinical practice
randomized controlled trial
systematic review
clinical trial
study protocol
replacement therapy
smoking cessation